Search results
A Life-long Asthma Patient Shares How She’s Learned to Manage Her Condition
Parade via Yahoo News· 12 months agoRashelle Stocker was diagnosed with asthma in third grade after having her first attack on the...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 14 hours agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
Theravance Biopharma (TBPH) to Sell Trelegy Royalty Interests
Zacks via Yahoo Finance· 2 years agoTheravance Biopharma (TBPH) agrees to sell its Trelegy royalty interests to Royalty Pharma. The...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 1 month agoGrace Cary / Getty Images Fact checked by Nick Blackmer Key Takeaways Three major pharmaceutical...
GSK to cap out-of-pocket inhaler costs in US
Reuters via Yahoo News· 1 month agoThe cost cap would apply to all of its asthma and chronic obstructive pulmonary disease (COPD) medicines, including Advair Diskus, Advair HFA, and...
See price hikes for top 25 drugs covered by Medicare; NJ drugmakers sue to stop change
App.com | Asbury Park Press via Yahoo Finance· 9 months agoAverage prices for 25 widely used drugs covered by Medicare more than tripled since they were...
Royalty Pharma plc (RPRX) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoThank you for joining us to review Royalty Pharma's second quarter 2022 results. All forward-looking...
GSK's Key Drugs to Drive Sales in a Sluggish Second Half
Zacks via Yahoo Finance· 2 years agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up...
Amazon Pharmacy now automatically applies coupons on select brand name drugs
TechCrunch· 1 year agoAmazon Pharmacy announced today that it will now automatically apply manufacturer coupons on brand...
GSK raises profit outlook on strong vaccine, HIV drug sales
Reuters via Yahoo Finance· 24 hours ago(Reuters) -GSK raised its full-year profit forecast on Wednesday on strong demand for its common...